2012
DOI: 10.1111/j.1468-3083.2012.04587.x
|View full text |Cite
|
Sign up to set email alerts
|

OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity

Abstract: Our findings provide evidence for the involvement of OX40 and OX40L in the pathogenesis of AD though they are not specific to AD and in vitro results suggest complex interaction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
25
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(27 citation statements)
references
References 41 publications
1
25
0
1
Order By: Relevance
“…The description of study subjects has been presented in our previous article (24). Briefly, 17 patients with moderate-to-severe AD (11 women and 6 men, mean age 35 years, range 19-69) volunteered to take part in the study after providing written informed consent.…”
Section: Study Subjects and Skin Biopsiesmentioning
confidence: 99%
See 1 more Smart Citation
“…The description of study subjects has been presented in our previous article (24). Briefly, 17 patients with moderate-to-severe AD (11 women and 6 men, mean age 35 years, range 19-69) volunteered to take part in the study after providing written informed consent.…”
Section: Study Subjects and Skin Biopsiesmentioning
confidence: 99%
“…The number and the percentage of IL-6 + MCs were compared to clinical parameters: the Rajka-Langeland Severity Index (mean 7 ± 1), the EASI score (mean 12.3 ± 6.6), the DLQI score (mean 12.7 ± 6.8), the levels of itching (mean 5.4 ± 2), and the total IgE serum levels of study subjects (1,862.3 ± 1,873.6 kU/l) (24). No correlations were detected between these parameters and the number or percentage of IL-6 + MCs.…”
Section: No Correlations Between Clinical Severity Of Ad and Il-6 + Mmentioning
confidence: 99%
“…in the absence of rh-SCF, and were stimulated with a dilution series of rh-IL-33 (R&D Systems) (as described in Results) for 2 days. 3 H-thymidine (85 Ci/mmol, Perkin-Elmer, Boston, MA, USA) in RPMI-1640 medium (Invitrogen) was added to the wells, and the cells were pulsed overnight, as described (20). The LAD2 cells were harvested using Combi Cell Harvester (Skatron Instruments AS, Lier, Norway) and the radioactivity was analysed with a liquid scintillation counter using ULTIMA Gold ™ liquid scintillation fluid (Perkin-Elmer) (20).…”
Section: Stimulation Of Lad2 Mast Cells With Il-33mentioning
confidence: 99%
“…27 In summary, 17 subjects with moderate-tosevere AD (11 women and 6 men; mean age, 35 years; range, 19Y69 years) participated in the study after providing written informed consent. Atopic dermatitis severity was measured by the Rajka-Langeland Severity Index (score range, 3Y9; scores 3Y4 denote mild, 4.5Y7.5 denote moderate, and 8Y9 denote severe disease).…”
Section: Study Subjects: Skin Biopsiesmentioning
confidence: 99%
“…Entry criteria are described in our previous article. 27 Four-millimeter punch biopsies were collected from lesional and nonlesional skin under local anesthesia. The nonlesional skin biopsy was taken at least 2 cm away from lesional skin.…”
Section: Study Subjects: Skin Biopsiesmentioning
confidence: 99%